BRYJA, Vítězslav, Pavlína JANOVSKÁ, Michaela GREGOROVÁ, Václav NĚMEC, PrashantKumar KHIRSARIYA and Kamil PARUCH. 4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors. 2022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name 4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Authors BRYJA, Vítězslav (203 Czech Republic, belonging to the institution), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), Michaela GREGOROVÁ (203 Czech Republic, belonging to the institution), Václav NĚMEC (203 Czech Republic, belonging to the institution), PrashantKumar KHIRSARIYA (356 India, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution).
Edition Number: US11498920, Publisher: United States Patent and Trademark Office, Place of publication: Alexandria, Virginia, Owner's name: Masarykova univerzita, 2022.
Other information
Original language English
Type of outcome Patent
Field of Study 10401 Organic chemistry
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14310/22:00128923
Organization unit Faculty of Science
Keywords in English lymphomas; leukaemia; solid tumors
Tags rivok
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 22/3/2023 13:35.
Abstract
Novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds that are useful in the treatment of lymphomas, leukaemias, and solid tumors.
PrintDisplayed: 24/7/2024 06:28